Follow
Kyra Zens
Title
Cited by
Cited by
Year
Vaccine-generated lung tissue–resident memory T cells provide heterosubtypic protection to influenza infection
KD Zens, JK Chen, DL Farber
JCI insight 1 (10), 2016
3982016
Human antibodies that bind lymphocyte activation gene-3 (lag-3) and uses thereof
KB Thudium, M Selby, KD Zens, M Yamanaka, AJ Korman, HN LeBlanc
US Patent App. 13/058,492, 2011
2102011
CD4+ T cell effector commitment coupled to self-renewal by asymmetric cell divisions
SA Nish, KD Zens, R Kratchmarov, WHW Lin, WC Adams, YH Chen, ...
Journal of Experimental Medicine 214 (1), 39-47, 2017
1112017
Memory CD4 T cells in influenza
KD Zens, DL Farber
Influenza pathogenesis and control-volume II, 399-421, 2014
1112014
Reduced generation of lung tissue–resident memory T cells during infancy
KD Zens, JK Chen, RS Guyer, FL Wu, F Cvetkovski, M Miron, DL Farber
Journal of Experimental Medicine 214 (10), 2915-2932, 2017
962017
Three-dimensional culture conditions lead to decreased radiation induced cytotoxicity in human mammary epithelial cells
MB Sowa, WB Chrisler, KD Zens, EJ Ashjian, LK Opresko
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 687 (1 …, 2010
452010
Developmental regulation of effector and resident memory T cell generation during pediatric viral respiratory tract infection
TJ Connors, JS Baird, MC Yopes, KD Zens, K Pethe, TM Ravindranath, ...
The Journal of Immunology 201 (2), 432-439, 2018
362018
Human antibodies that bind CD22 and uses thereof
DJ King, A Witte, HN LeBlanc, R Theolis, A Masood, M Yamanaka, ...
US Patent 8,481,683, 2013
362013
Immunogenicity and safety of the tick-borne encephalitis vaccination (2009–2019): A systematic review
JE Rampa, HH Askling, P Lang, KD Zens, N Gültekin, Z Stanga, ...
Travel medicine and infectious disease 37, 101876, 2020
292020
Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof
KB Thudium, MJ Selby, KD Zens, M Yamanaka, AJ Korman, HN LeBlanc
US Patent 10,344,089, 2019
292019
Infection and immune control of human oncogenic γ-herpesviruses in humanized mice
D McHugh, N Caduff, A Murer, C Engelmann, Y Deng, H Zdimerova, ...
Philosophical Transactions of the Royal Society B 374 (1773), 20180296, 2019
262019
Analysis of Tick-borne Encephalitis vaccination coverage and compliance in adults in Switzerland, 2018
V Baroutsou, KD Zens, P Sinniger, J Fehr, P Lang
Vaccine 38 (49), 7825-7833, 2020
242020
CD27 is required for protective lytic EBV antigen–specific CD8+ T-cell expansion
Y Deng, B Chatterjee, K Zens, H Zdimerova, A Müller, P Schuhmachers, ...
Blood, The Journal of the American Society of Hematology 137 (23), 3225-3236, 2021
222021
Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort
D Menges, KD Zens, T Ballouz, N Caduff, D Llanas-Cornejo, ...
Nature Communications 13 (1), 4855, 2022
212022
T‐cell memory in tissues
KPJM van Gisbergen, KD Zens, C Münz
European journal of immunology 51 (6), 1310-1324, 2021
162021
A microbial-based cancer vaccine for induction of EGFRvIII-specific CD8+ T cells and anti-tumor immunity
L Zebertavage, S Bambina, J Shugart, A Alice, KD Zens, P Lauer, ...
Plos one 14 (1), e0209153, 2019
162019
Tissue compartmentalization of T cell responses during early life
KD Zens, T Connors, DL Farber
Seminars in immunopathology 39, 593-604, 2017
162017
Retrospective, matched case–control analysis of tickborne encephalitis vaccine effectiveness by booster interval, Switzerland 2006–2020
KD Zens, SR Haile, AJ Schmidt, ES Altpeter, JS Fehr, P Lang
BMJ open 12 (4), e061228, 2022
122022
Human antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereof
KB Thudium, MJ Selby, KD Zens, M Yamanaka, AJ Korman, HN LeBlanc
US Patent App. 16/722,296, 2020
122020
Human antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereof
KB Thudium, MJ Selby, KD Zens, M Yamanaka, AJ Korman, HN LeBlanc
US Patent App. 16/419,940, 2019
122019
The system can't perform the operation now. Try again later.
Articles 1–20